NEW YORK (GenomeWeb) – Ceres Nanosciences announced today it has closed on $3 million in Series A financing, part of what the company said was a larger $9 million Series A round.

The round was led by Concord, Massachusetts-based venture firm GreyBird Ventures, which has said it intends to provide a total of up to $5.5 million in funds over the next year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.